NCT02740413
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
- Locations
-
Not specified
Clinical trial condition
Coagulation Protein Disorders
Explore clinical trials studying Coagulation Protein Disorders. Study availability and eligibility vary by location and protocol.
784 public trials
106 recruiting studies
Coagulation Protein Disorders trial results
NCT01154231
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
- Locations
-
- Tokyo Medical University Hospital Shinjuku-ku, Tokyo, Japan
Completed
Pharmacokinetic, Efficacy and Safety of BT524 in Patients With Congenital Fibrinogen Deficiency
NCT02065882
- Conditions
- Afibrinogenemia, Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, +11 more
- Locations
-
- Site 15 Sofia, Bulgaria
- Site 11 Cairo, Egypt
- Site 16 Frankfurt, Germany
- Site 01 Beirut, Lebanon
NCT05879549
- Conditions
- Behavior, Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, +10 more
- Locations
-
- İstanbul University-Cerrahpaşa Istanbul, Turkey (Türkiye)
NCT04091386
- Conditions
- Behavior, Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, +8 more
- Locations
-
- Center for Comprehensive Care and Diagnosis of Inherited Blood Disorders Orange, California, United States
- Tulane University New Orleans, Louisiana, United States
- Many Locations Multiple Locations, Belgium
- Many Locations Multiple Locations, Canada
Completed
Adjusted Fibrinogen Replacement Strategy
NCT03444324
- Conditions
- Afibrinogenemia, Bleeding Disorder, Blood Coagulation Disorders, +11 more
- Locations
-
- Site 02 Jette, Belgium
- Site 01 Leuven, Belgium
- Site 54 Brno, Czechia
- Site 51 Prague, Czechia
NCT00868530
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
- Locations
-
- Pfizer Investigational Site Suzhou, Jiangsu, China
- Pfizer Investigational Site Heping District, Tianjin Municipality, China
- Pfizer Investigational Site Hangzhou, Zhejiang, China
- Pfizer Investigational Site Beijing, China
NCT03938792
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +11 more
- Locations
-
- USF Health Morsani Center For Advanced Healthcare Tampa, Florida, United States
- University of Iowa Iowa City, Iowa, United States
- Northwell Health HTC New Hyde Park, New York, United States
- Washington Institute for Coagulation Seattle, Washington, United States
NCT05437211
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
- Locations
-
- Centre de Reference Hemophilie Unite D'Hemostase Clinique Bron, Auvergne-Rhône-Alpes, France
- CHU Estaing Clermont-Ferrand, Auvergne-Rhône-Alpes, France
- Hôpital de Hautepierre - Pôle MIRMED Strasbourg, Grand Est, France
- CHU Purpan Toulouse, Haute-Garonne, France
Completed
A Study of Adynovate in Previously Treated Chinese Teenagers and Adults With Severe Hemophilia A
NCT05707351
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
- Locations
-
- Beijing Children's Hospital, Capital Medical University Beijing, China
- Peking Union Medical College Hospital, Chinese Academy of Medical Sciences Beijing, China
- Xiangya Hospital of Central South University Changsha, China
- Fujian Medical University Union Hospital Fuzhou, China